Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Takahisa, Mikami"'
Autor:
Shuhei Nishiyama, Jin Myong Seok, Amy E. Wright, Itay Lotan, Takahisa Mikami, Natalia C. Drosu, Natasha Bobrowski-Khoury, Monique R. Anderson, Philippe A. Bilodeau, Patrick Schindler, Friedemann Paul, Masashi Aoki, Michael R. Yeaman, Michael Levy, The Guthy-Jackson Charitable Foundation CIRCLES Study Group
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Proinflammatory cytokines, such as (IL: interleukin) IL-6 and IL-17A, and complement fixation are critical in the immunopathogenesis of neuromyelitis optica spectrum disorders (NMOSD). Blocking the IL-6 receptor or the C5 complement pathway
Externí odkaz:
https://doaj.org/article/aedaf31a7f7349ebb6c22664c55bd90c
Autor:
Shuhei Nishiyama, Amy E. Wright, Itay Lotan, Takahisa Mikami, Friedemann Paul, Masashi Aoki, Michael Levy
Publikováno v:
Journal of Neuroinflammation, Vol 19, Iss 1, Pp 1-12 (2022)
Abstract Background and objectives Inhibition of terminal complement in neuromyelitis optica spectrum disorder (NMOSD) using eculizumab helps prevent relapses, but the exact mechanism of action of the drug remains unclear. Similarly, genetic variants
Externí odkaz:
https://doaj.org/article/432b476f9f364c768eb8a44d193ed7ae
Autor:
Drosu, Natalia, Anderson, Monique, Bilodeau, Philippe A., Shuhei Nishiyama, Takahisa Mikami, Bobrowski-Khoury, Natasha, Cabot, Jackson, Housman, David, Levy, Michael
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 10/29/2024, Vol. 121 Issue 44, p1-9, 31p
Autor:
Toshiki Kuno, Takahisa Mikami, Yuki Sahashi, Yohei Numasawa, Masahiro Suzuki, Shigetaka Noma, Keiichi Fukuda, Shun Kohsaka
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Acute kidney injury (AKI) after percutaneous coronary intervention (PCI) is associated with a significant risk of morbidity and mortality. The traditional risk model provided by the National Cardiovascular Data Registry (NCDR) is useful for
Externí odkaz:
https://doaj.org/article/47e7377e669f4dbfb3e3fbd7ffe29127
Autor:
Takayuki Yamada, Mako Wakabayashi, Abhinav Bhalla, Nitin Chopra, Hirotaka Miyashita, Takahisa Mikami, Hiroki Ueyama, Tomohiro Fujisaki, Yusuke Saigusa, Takahiro Yamaji, Kengo Azushima, Shingo Urate, Toru Suzuki, Eriko Abe, Hiromichi Wakui, Kouichi Tamura
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)
Abstract Background Emerging evidence suggests that sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with decreased risk of cardiovascular and renal events in type 2 diabetes
Externí odkaz:
https://doaj.org/article/e6c2b71e9a38482fac5cfbb79eaefc02
Autor:
Shinobu Itagaki, Nana Toyoda, Noah Moss, Donna Mancini, Natalia Egorova, Takahisa Mikami, Erick Sun, Yuki Bekki, Gregory Serrao, Anuradha Lala, Percy Boateng, David H. Adams, Anelechi C. Anyanwu
Publikováno v:
Journal of the American College of Cardiology. 81:729-740
Autor:
Yujiro Yokoyama, Tomoki Sakata, Takahisa Mikami, Naoki Misumida, Andrea Scotti, Hisato Takagi, Tadahisa Sugiura, Toshiki Kuno, Azeem Latib
Publikováno v:
Journal of Cardiology.
Publikováno v:
Internal Medicine
The legalization of recreational marijuana in some countries has been accompanied by an increased number of case reports of serious cardiovascular and cerebrovascular complications. However, there have been few studies describing the detailed clinica
Autor:
Chikashi Nakai, Takahisa Mikami, Takuro Tsukube, Soichiro Henmi, Tomonori Haraguchi, So Izumi, Shinichi Nakayama
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 165:984-991.e1
We analyzed patients with acute type A aortic dissection complicated by malperfusion syndrome to establish whether the timing of operative treatment and the location of malperfusion are factors in determining outcomes.A total of 331 patients with acu
Autor:
Yoshihiro Uesawa, Masayuki Chuma, Takahiro Niimura, Keisuke Ishizawa, Mizuho Asada, Takahisa Mikami, Yoshito Zamami
Publikováno v:
Oncology. 99:256-259
Background: Pneumonitis is a serious adverse event in patients treated with immune checkpoint inhibitors (ICIs), with a mortality rate of up to 20%. The risk factors for ICI-related pneumonitis remain unclear due to the scarce data and infrequent eve